JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB20181

Anti-HLA-DR 抗体 [TAL 1B5]

Anti-HLA-DR antibody [TAL 1B5]

5

(6 Reviews)

|

(51 Publications)

Anti-HLA-DR antibody [TAL 1B5] (ab20181) is a mouse monoclonal antibody detecting HLA-DR in Western Blot, Flow Cytometry, IHC-P, ICC/IF. Suitable for Human.

- Biophysical QC for unrivalled batch-batch consistency
- Over 50 publications
- Trusted since 2005

查看别名

HLA-DRA1, HLA-DRA, MHC class II antigen DRA

7 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HLA-DR antibody [TAL 1B5] (AB20181)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HLA-DR antibody [TAL 1B5] (AB20181)

Immunohistochemical analysis of paraffin-embedded human skin tissue labeling HLA-DR with ab20181 at 0.1 μg/ml followed by Leica DS9800 (Bond™ Polymer Refine Detection). The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20mins. The section was then incubated with ab20181, 0.1ug/ml, for 15 mins at room temperature and was then detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

Immunocytochemistry/ Immunofluorescence - Anti-HLA-DR antibody [TAL 1B5] (AB20181)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-HLA-DR antibody [TAL 1B5] (AB20181)

ab20181 staining HLA DR in Raji cells. The cells were fixed with 4% formaldehyde (10 min), permeabilised in 0.1% Triton X-100 for 5 minutes and then blocked in 1% BSA/10% normal goat serum/0.3M glycine in 0.1%PBS-Tween for 1h. The cells were then incubated overnight at +4°C with ab20181 at 1/1000 dilution and ab7291, Mouse monoclonal to alpha Tubulin at 1/1000 dilution. Cells were then incubated with ab150119, Goat Anti-Mouse IgG H&L (Alexa Fluor® 647) preadsorbed, at 1/1000 dilution (shown in red) and ab150081, Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488), preadsorbed at 1/1000 dilution (shown in green). Nuclear DNA was labelled with DAPI (shown in blue). Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HLA-DR antibody [TAL 1B5] (AB20181)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HLA-DR antibody [TAL 1B5] (AB20181)

Immunohistochemical analysis of formalin fixed paraffin embedded human tonsil labelling HLA-DR with ab20181 at a concentration of 0.01µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins.

ab20181 Anti-HLA-DR antibody [TAL 1B5] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.

Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).

Western blot - Anti-HLA-DR antibody [TAL 1B5] (AB20181)
  • WB

AbReview28146****

Western blot - Anti-HLA-DR antibody [TAL 1B5] (AB20181)

This image was generated from a previous batch made using the hybridoma production method.

All lanes:

Western blot - Anti-HLA-DR antibody [TAL 1B5] (ab20181) at 0.667 µg/mL

All lanes:

whole tissue lysate prepared from human colon at 50 µg

Secondary

All lanes:

HRP conjugated goat anti-mouse polyclonal at 1/3000 dilution

Predicted band size: 29 kDa

Observed band size: 33 kDa

true

Exposure time: 5s

Image courtesy of an anonymous Abreview.

Flow Cytometry - Anti-HLA-DR antibody [TAL 1B5] (AB20181)
  • Flow Cyt

Lab

Flow Cytometry - Anti-HLA-DR antibody [TAL 1B5] (AB20181)

Flow cytometry staining of human peripheral blood mononuclear cells (PBMCs) with ab20181 (right) or mouse IgG1κ (ab170190) isotype (left). PBMCs were incubated for 30 min on ice in 1x PBS containing 10μg/ml human IgG and 10% normal goat serum to block FC receptors and non-specific protein-protein interaction followed by followed by staining with CD19 APC. PBMCs were then fixed in 4.2% formaldehyde and permeabilised in 0.1% saponin before staining with the antibody (ab20181) or mouse IgG1κ (ab170190) isotype (1x106 in 100μl; at 0.008μg/ml) for 30 min on ice. The secondary antibody Goat anti-mouse IgG H&L (Alexa Fluor ® 488, pre-adsorbed) (ab150117) was used at 1 : 2000 dilution for 30 min on ice. Acquisition of >30000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter. Events were gated on alive lymphocytes.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HLA-DR antibody [TAL 1B5] (AB20181)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HLA-DR antibody [TAL 1B5] (AB20181)

Immunohistochemical analysis of paraffin-embedded human tonsil tissue labeling HLA-DR with ab20181 at 0.1 μg/ml followed by Leica DS9800 (Bond™ Polymer Refine Detection). The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20mins. The section was then incubated with ab20181, 0.1ug/ml, for 15 mins at room temperature and was then detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

Western blot - Anti-HLA-DR antibody [TAL 1B5] (AB20181)
  • WB

Lab

Western blot - Anti-HLA-DR antibody [TAL 1B5] (AB20181)

Lanes 1-3 : Merged signal (red and green). Green - ab20181 observed at 35 kDa. Red - loading control ab181602 (Rabbit Anti-GAPDH antibody [EPR16891]) observed at 37 kDa. ab20181 was shown to react with HLA-DR in Western blot. Membranes were blocked with 3% milk in TBS-T (0.1% Tween®) before incubation with ab20181 and ab181602 (Rabbit Anti-GAPDH antibody [EPR16891]) overnight at 4°C at 1 µg/ml and a 1 : 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 : 20000 dilution for 1 h at room temperature before imaging.

All lanes:

Western blot - Anti-HLA-DR antibody [TAL 1B5] (ab20181) at 1/1000 dilution

Lane 1:

Raji whole cell lysate at 20 µg

Lane 2:

Daudi whole cell lysate at 20 µg

Lane 3:

HEK-293 whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/20000 dilution

Observed band size: 35 kDa

true

不同偶联物与剂型 (5)

关键信息

宿主种属

Mouse

克隆

Monoclonal

克隆号

TAL 1B5

亚型

IgG1

轻链类型

kappa

不含载体蛋白

No

反应种属

Human

应用

ICC/IF, IHC-P, WB, Flow Cyt

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/1000", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "5 µg/mL", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "0.008 µg/mL", "FlowCyt-species-notes": "<p><a href='/products/primary-antibodies/mouse-igg1-kappa-monoclonal-15-6e10a7-isotype-control-ab170190'>ab170190</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>" } } }

您可能对以下产品感兴趣:

AB223593

Human HLA-DR ELISA Kit

0

0 Reviews

查看产品
为什么推荐这个?

我们推荐这个产品,因为它经常被用于相同的实验或相关的研究。

我们建议您务必查阅产品说明书,以确认其是否符合您的实验需求;若有疑问,也可联系我们的技术团队获取协助。

产品详情

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Protein A
存储溶液
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
运输条件
Blue Ice
推荐的短期储存时间
1-2 weeks
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
分装信息
Upon delivery aliquot
储存信息
Avoid freeze / thaw cycle

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

An alpha chain of antigen-presenting major histocompatibility complex class II (MHCII) molecule. In complex with the beta chain HLA-DRB, displays antigenic peptides on professional antigen presenting cells (APCs) for recognition by alpha-beta T cell receptor (TCR) on HLA-DR-restricted CD4-positive T cells. This guides antigen-specific T-helper effector functions, both antibody-mediated immune response and macrophage activation, to ultimately eliminate the infectious agents and transformed cells (PubMed : 15265931, PubMed : 15322540, PubMed : 17334368, PubMed : 22327072, PubMed : 24190431, PubMed : 27591323, PubMed : 29884618, PubMed : 31495665, PubMed : 8145819, PubMed : 9075930). Typically presents extracellular peptide antigens of 10 to 30 amino acids that arise from proteolysis of endocytosed antigens in lysosomes (PubMed : 8145819). In the tumor microenvironment, presents antigenic peptides that are primarily generated in tumor-resident APCs likely via phagocytosis of apoptotic tumor cells or macropinocytosis of secreted tumor proteins (PubMed : 31495665). Presents peptides derived from intracellular proteins that are trapped in autolysosomes after macroautophagy, a mechanism especially relevant for T cell selection in the thymus and central immune tolerance (PubMed : 17182262, PubMed : 23783831). The selection of the immunodominant epitopes follows two processing modes : 'bind first, cut/trim later' for pathogen-derived antigenic peptides and 'cut first, bind later' for autoantigens/self-peptides (PubMed : 25413013). The anchor residue at position 1 of the peptide N-terminus, usually a large hydrophobic residue, is essential for high affinity interaction with MHCII molecules (PubMed : 8145819).
See full target information HLA-DRA

文献 (51)

Recent publications for all applications. Explore the full list and refine your search

iScience 26:107585 PubMed37694144

2023

Multi-omic approach identifies hypoxic tumor-associated myeloid cells that drive immunobiology of high-risk pediatric ependymoma.

Applications

Unspecified application

Species

Unspecified reactive species

Andrea M Griesinger,Kent Riemondy,Nithyashri Eswaran,Andrew M Donson,Nicholas Willard,Eric W Prince,Simon M L Paine,Georgia Bowes,John Rheaume,Rebecca J Chapman,Judith Ramage,Andrew Jackson,Richard G Grundy,Nicholas K Foreman,Timothy A Ritzmann

JCI insight 8: PubMed37252795

2023

The MIF promoter SNP rs755622 is associated with immune activation in glioblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Tyler J Alban,Matthew M Grabowski,Balint Otvos,Defne Bayik,Wesley Wang,Ajay Zalavadia,Vlad Makarov,Katie Troike,Mary McGraw,Anja Rabljenovic,Adam Lauko,Chase Neumann,Gustavo Roversi,Kristin A Waite,Gino Cioffi,Nirav Patil,Thuy T Tran,Kathleen McCortney,Alicia Steffens,C Marcela Diaz,J Mark Brown,Kathleen M Egan,Craig M Horbinski,Jill S Barnholtz-Sloan,Prajwal Rajappa,Michael A Vogelbaum,Richard Bucala,Timothy A Chan,Manmeet S Ahluwalia,Justin D Lathia

Cancer research communications 3:896-907 PubMed37377902

2023

EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Ritu Chaudhary,Robbert J C Slebos,Leenil C Noel,Feifei Song,Maria I Poole,Dirk S Hoening,Juan C Hernandez-Prera,Jose R Conejo-Garcia,Jose A Guevara-Patino,Xuefeng Wang,Mengyu Xie,Aik Choon Tan,Christine H Chung

Nature 617:807-817 PubMed37198490

2023

Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Reza Naghavian,Wolfgang Faigle,Pietro Oldrati,Jian Wang,Nora C Toussaint,Yuhan Qiu,Gioele Medici,Marcel Wacker,Lena K Freudenmann,Pierre-Emmanuel Bonté,Michael Weller,Luca Regli,Sebastian Amigorena,Hans-Georg Rammensee,Juliane S Walz,Silvio D Brugger,Malte Mohme,Yingdong Zhao,Mireia Sospedra,Marian C Neidert,Roland Martin

Molecular & cellular proteomics : MCP 22:100563 PubMed37142057

2023

Sensitive, High-Throughput HLA-I and HLA-II Immunopeptidomics Using Parallel Accumulation-Serial Fragmentation Mass Spectrometry.

Applications

Unspecified application

Species

Unspecified reactive species

Kshiti Meera Phulphagar,Claudia Ctortecka,Alvaro Sebastian Vaca Jacome,Susan Klaeger,Eva K Verzani,Gabrielle M Hernandez,Namrata D Udeshi,Karl R Clauser,Jennifer G Abelin,Steven A Carr

Nature communications 14:1851 PubMed37012232

2023

Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues.

Applications

Unspecified application

Species

Unspecified reactive species

Jennifer G Abelin,Erik J Bergstrom,Keith D Rivera,Hannah B Taylor,Susan Klaeger,Charles Xu,Eva K Verzani,C Jackson White,Hilina B Woldemichael,Maya Virshup,Meagan E Olive,Myranda Maynard,Stephanie A Vartany,Joseph D Allen,Kshiti Phulphagar,M Harry Kane,Suzanna Rachimi,D R Mani,Michael A Gillette,Shankha Satpathy,Karl R Clauser,Namrata D Udeshi,Steven A Carr

Cell reports. Medicine 4:100977 PubMed36921599

2023

Multiplex imaging of breast cancer lymph node metastases identifies prognostic single-cell populations independent of clinical classifiers.

Applications

Unspecified application

Species

Unspecified reactive species

Jana Raja Fischer,Hartland Warren Jackson,Natalie de Souza,Zsuzsanna Varga,Peter Schraml,Holger Moch,Bernd Bodenmiller

Adipocyte 12:2173513 PubMed36775902

2023

Highly-expressed lncRNA FOXD2-AS1 in adipose mesenchymal stem cell derived exosomes affects HaCaT cells via regulating miR-185-5p/ROCK2 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Huanchao Chang,Junliang Chen,Kun Ding,Tianling Cheng,Shengjian Tang

Cancers 15: PubMed36765788

2023

Characterization of Estrogen Receptors in Pancreatic Adenocarcinoma with Tertiary Lymphoid Structures.

Applications

Unspecified application

Species

Unspecified reactive species

Xuan Zou,Yu Liu,Xuan Lin,Ruijie Wang,Zhengjie Dai,Yusheng Chen,Mingjian Ma,Yesiboli Tasiheng,Yu Yan,Xu Wang,Xianjun Yu,He Cheng,Chen Liu

Frontiers in oncology 12:1012058 PubMed36338744

2022

Multi-spectral immunofluorescence evaluation of the myeloid, T cell, and natural killer cell tumor immune microenvironment in chordoma may guide immunotherapeutic strategies.

Applications

Unspecified application

Species

Unspecified reactive species

Diana C Lopez,Yvette L Robbins,Joshua T Kowalczyk,Wiem Lassoued,James L Gulley,Markku M Miettinen,Gary L Gallia,Clint T Allen,James W Hodge,Nyall R London
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

关联产品

Select an associated product type
Alternative Product
Primary Antibodies

AB244584

Anti-HLA-DR antibody [DA6.147] - BSA and Azide free

primary-antibodies

hla-dr-antibody-da6147-bsa-and-azide-free-ab244584

0

(0 reviews)

Alternative Product
Primary Antibodies

AB238469

Anti-HLA-DR antibody [DA6.147]

primary-antibodies

hla-dr-antibody-da6147-ab238469

0

(0 reviews)

Alternative Product
Primary Antibodies

AB92511

Anti-HLA-DR antibody [EPR3692]

primary-antibodies

hla-dr-antibody-epr3692-ab92511

4

(7 reviews)

Alternative Product
Primary Antibodies

AB124809

Anti-HLA-DR antibody [EPR3691(2)]

primary-antibodies

hla-dr-antibody-epr36912-ab124809

0

(0 reviews)

Alternative Product
Primary Antibodies

AB215985

Anti-HLA-DR antibody [EPR3692] - Low endotoxin, Azide free

primary-antibodies

hla-dr-antibody-epr3692-low-endotoxin-azide-free-ab215985

5

(1 reviews)

Alternative Product
Primary Antibodies

AB215312

Alexa Fluor® 555 Anti-HLA-DR antibody [EPR3692]

primary-antibodies

alexa-fluor-555-hla-dr-antibody-epr3692-ab215312

0

(0 reviews)

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com